PEPLIN

WIPO WIPO 2010

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark PEPLIN was filed as Word mark on 10/08/2010 at the World Intellectual Property Organization.

Trademark Details Last update: November 11, 2021

Trademark form Word mark
File reference 1058228
Countries Albania Armenia Azerbaijan Bosnia and Herzegovina Bahrain Bonaire, Sint Eustatius and Saba Bhutan Botswana Belarus Switzerland China Egypt Georgia Croatia Israel Iran Iceland Japan Kenya Kyrgyzstan South Korea Liechtenstein Morocco Monaco Moldova Montenegro Madagascar Macedonia Mozambique Namibia Norway Oman Serbia Russia Sudan Singapore San Marino Sint Maarten Syria Turkmenistan Turkey Ukraine Uzbekistan Vietnam Zambia
Base trademark DK No. VA 2010 02619, September 2, 2010
Application date October 8, 2010
Expiration date October 8, 2020

Trademark owner

Industriparken 55
2750 Ballerup
DK

goods and services

05 Vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment of cancers, namely, tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lungs as well as solid and blood borne tumors such as ABL l proto-oncogene, AIDS related cancers, acoustic neuroma, acute lymphocyte leukemia, acute myeloid leukemia, adenocystic carcinoma, adrenocortical cancer, agnogenic myeloid metaplasia, alopecia, alveolar soft-part sarcoma, anal cancer, angio-sarcoma, aplastic anemia, astrocytoma, ataxia-telangiectasia, basal cell carcinoma, bladder cancer, bone cancers, bowel cancer, brain stem glioma, brain and CNS tumors, breast cancer, CNS tumors, carcinoid tumors, cervical cancer, childhood brain tumors, childhood cancer, childhood leukemia, childhood soft tissue sarcoma, chondrosarcoma, choriocarcinoma, chronic lymphocytic leukemia, chronic myeloid leukemia, colorectal cancers, cutaneous T-cell lymphoma, dermatofibrosarcoma proruberans, desmoplastic-small-round-cell-tumor, ductal carcinoma, endocrine cancers, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, extra-hepatic bile duct cancer, eye cancer, fallopian tube cancer, fanconi anemia, fibrosarcoma, gall bladder cancer, gastric cancer, gastrointestinal cancers, gastrointestinal carcinoid tumor, genitourinary cancers, germ cell tumors, gestational trophoblastic disease, glioma, gynecological cancers, hematological malignancies, hairy cell leukemia, head and neck cancer, hepatocellular cancer, hereditary breast cancer, histiocytosis, Hodgkin's disease, human papillomavirus, hydatidiform raole, hypercalcemia, hypopharynx cancer, intraocular melanoma, islet cell cancer, Kaposi's sarcoma, kidney cancer, Langerhan's cell histiocytosis, laryngeal cancer, leiomyosarcoma, leukemia, Li-Fraumeni syndrome, lip cancer, liposarcoma, liver cancer, lung cancer, lymphedema, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, male breast cancer, malignant rhabdoid tumor of kidney, medulloblastoma, melanoma, Merkel cell cancer, mesothelioma, metastatic cancer, mouth cancer, multiple endocrine neoplasia, mycosis fungoides, myelodysplastic syndromes, myeloma, myeloproliferative disorders, nasal cancer, nasopharyngeal cancer, nephroblastoma, neuroblastoma, neurofibromatosis, Nijmegen breakage syndrome, non-melanoma skin cancer, non-small cell lung cancer, ocular cancers, oesophageal cancer, oral cavity cancer, oropharynx cancer, osteosarcoma, ostomy, ovarian cancer, pancreas cancer, paranasal cancer, parathyroid cancer, parotid gland cancer, penile cancer, peripheral neuroectodermal tumors, pituitary cancer, polycythemia vera, prostate cancer, rare cancers and associated disorders, renal cell carcinoma, retinoblastoma, rhabdomyosarcoma, Rothmund-Thomson syndrome, salivary gland cancer, schwannoma, Sezary syndrome, skin cancer, small cell lung cancer, small intestine cancer, soft tissue sarcoma, spinal cord tumors, squamous cell carcinoma, stomach cancer, synovial sarcoma, testicular cancer, thymus cancer, thyroid cancer, transitional cell cancer of the bladder, transitional cell cancer of the renal, pelvis and ureter, trophoblastic cancer, urethral cancer, urinary system cancer, uroplakins, uterine sarcoma, uterus cancer, vaginal cancer, vulva cancer, Waldenstrom's macroglobulinemia and Wilms' tumor; pharmaceutical preparations namely, alimentary tract and metabolism, antineoplastic and immunomodulating agents, anti-infectives for systemic use; dermatological preparations

Trademark history

Date Document number Area Entry
November 10, 2021 2021/45 Gaz Deletion
April 2, 2013 2013/22 Gaz SY Rejection
October 19, 2012 2012/43 Gaz TR Rejection
May 22, 2012 2012/21 Gaz TM Rejection
January 11, 2012 2012/4 Gaz RU RAW: Rule 18ter(2)(i) GP following a provisional refusal
January 9, 2012 2012/5 Gaz BY Rejection
December 16, 2011 2011/51 Gaz VN Rejection
December 14, 2011 2011/51 Gaz SY Rejection
December 9, 2011 2012/2 Gaz ME Rejection
December 7, 2011 2011/50 Gaz MG Rejection
December 2, 2011 2011/51 Gaz CH Rejection
November 22, 2011 2011/47 Gaz GE Rejection
November 21, 2011 2011/49 Gaz HR Rejection
November 17, 2011 2011/49 Gaz BA Rejection
November 4, 2011 2011/45 Gaz UA Rejection
November 3, 2011 2012/5 Gaz IL Rejection
October 27, 2011 2011/45 Gaz RS Rejection
October 14, 2011 2011/42 Gaz AM Rejection
October 9, 2011 2011/41 Gaz KR Rejection
September 21, 2011 2011/40 Gaz KG Rejection
September 20, 2011 2011/39 Gaz RU Rejection
September 16, 2011 2011/37 Gaz MD Rejection
August 15, 2011 2011/40 Gaz CN Rejection
July 15, 2011 2011/29 Gaz NO Rejection
July 7, 2011 2011/28 Gaz SM Rejection
June 6, 2011 2011/23 Gaz IS Rejection
May 16, 2011 2011/27 Gaz SX Rejection
May 4, 2011 2011/25 Gaz SG Rejection
April 14, 2011 2011/15 Gaz JP Rejection
December 2, 2010 2010/51 Gaz Correction
October 8, 2010 2010/48 Gaz DK Registration

ID: 141058228